Corona Remedies makes bumper debut on the BSE
Corona Remedies has debuted at Rs 1452.00 on the BSE, up by 390 points or 36.72% from its issue price of Rs 1062.00.
The scrip is currently trading at Rs. 1474.60, up by 412.6 points or 38.85% from its issue price.
It has touched a high and low of Rs. 1499.00 and Rs. 1430.10 respectively. So far 9.79 lakh shares were traded on the counter.
The offering, which was open for subscription between December 08, 2025 and December 10, 2025 was subscribed 144.54 times. The issue price was fixed at Rs 1062.00 per share i.e. at upper end of price band of Rs 1008-1062 apiece.
Corona Remedies is an India-focused branded pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas.
